Transhepatic arterial chemoembolization with oxaliplatin-eluting microspheres (OEM-TACE) for unresectable hepatic tumors

Anticancer Research

Volumn 28, Issue 6 B, 2008, Pages 3835-3842

  Poggi, Guido ^a,c   Quaretti, Pietro ^a   Minoia, Claudio ^a   Bernardo, Giovanni ^a   Bonora, Mario Regazzi ^b   Gaggeri, Raffaella ^a   Ronchi, Anna ^a   Saluzzo, Cesare Massa ^b   Azzaretti, Andrea ^b   Rodolico, Giuseppe ^b   Montagna, Michela ^b   Amatu, Alessio ^a   Teragni, Cristina ^a   Palumbo, Ilaria ^a   Traverso, Elena ^a   Tonini, Stefano ^a   Villani, Laura ^a   Scelsi, Mario ^a   Baiardi, Paola ^a   Felisi, Maria Grazia ^a   Sottotetti, Federico ^a   Tagliaferri, Barbara ^a   Riccardi, Alberto ^a   more..

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c IRCCS   (Italy)

Author keywords

Liver interventional procedures; Liver neoplasms; Radiofrequency (RF) ablation; Transhepatic arterial chemoembolization (TACE)

Indexed keywords

ANTIHISTAMINIC AGENT; CODEINE; FLUOROURACIL; FOLINIC ACID; MICROSPHERE; OXALIPLATIN; PARACETAMOL;

ABDOMINAL PAIN; ACUTE CHOLECYSTITIS; ADULT; AGED; ALOPECIA; AMINOTRANSFERASE BLOOD LEVEL; AMYLASE BLOOD LEVEL; AREA UNDER THE CURVE; ARTICLE; BILE DUCT CARCINOMA; BILE DUCT INJURY; BLOOD VESSEL INJURY; BONE MARROW TOXICITY; CANCER CHEMOTHERAPY; CANCER SURGERY; CHEMOEMBOLIZATION; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; DRUG BINDING; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG ERUPTION; DRUG FEVER; DRUG LIVER LEVEL; DRUG TISSUE LEVEL; DRUG TUMOR LEVEL; FEASIBILITY STUDY; FEMALE; HUMAN; HUMAN TISSUE; LIVER ABSCESS; LIVER BIOPSY; LIVER FUNCTION; LIVER METASTASIS; MALE; MASS SPECTROMETRY; MAXIMUM PLASMA CONCENTRATION; MULTIPLE CYCLE TREATMENT; NAUSEA; ORTICARIOID RASH; PANCREATITIS; PATIENT SAFETY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SIDE EFFECT; TIME TO MAXIMUM PLASMA CONCENTRATION; TRANSHEPATIC ARTERIAL CHEMOEMBOLIZATION; TREATMENT OUTCOME; TREATMENT RESPONSE; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; TUMOR GROWTH;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CHEMOEMBOLIZATION, THERAPEUTIC; CHOLANGIOCARCINOMA; DRUG DELIVERY SYSTEMS; FEASIBILITY STUDIES; FEMALE; HEPATIC ARTERY; HUMANS; LIVER NEOPLASMS; MALE; MICROSPHERES; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; SURVIVAL RATE;

EID: 58149151512     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Llovet JM, Real MI, Montana X et al: Arterial embolization or chemoembolization versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359: 1734-1739, 2002.
2. Lo CM, Ngan H, Tso WK et al: Randomized controlled trial of transarterial lipiodol chemoembolization for hepatocellular carcinoma: is there room for new studies? Clin Gastroenterol 32: 383-389, 2001.
3. Camma C, Schepis F, Orlando A et al: Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized trial. Radiology 224: 47-54, 2002.
4. Llovet JM and Bruix J: Systematic review of randomized trials for unresectable hepatocellular carcinoma:chemoembolization improves survival. Hepatology 37: 429-442, 2003.
5. Taylor RR, Tang Y, Gonzalez MV et al: Irinotecan drug eluting beads for use in chemoembolization: in vitro and in vivo evaluation of drug release properties. Eur J Pharm Sci 30: 7-14, 2007.
6. Salman HS, Cynamon J, Jagust M et al: Randomized phase II trial of embolization therapy versus chemoembolization therapy in previously treated patients with colorectal carcinoma metastatic to the liver. Clin Colorectal Cancer 2: 173-179, 2002.
7. Soulen MC: Regional therapy of hepatic malignancies. Curr Treat Options Gastroenterol 2: 437-440, 1999.
8. Tellez C, Benson AB, Lyster MT et al: Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature. Cancer 82: 1250-1259, 1998.
9. Abramson RG, Rosen MP, Perry LJ et al: Cost-effectiveness of hepatic arterial chemoembolization for colorectal liver metastases refractory to systemic chemotherapy. Radiology 216: 485-491, 2000.
10. Burger I, Hong K, Schulick R et al: Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution. J Vasc Interv Radiol 16: 353-361, 2005.
11. Hong K, Khwaja A, Liapi E et al: New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer. Clin Cancer Res 12: 2563-2567, 2006.
12. André T, Louvet C, Raymond E: Bimonthly high-dose leucovorin, 5-fluorouracil infusion and oxaliplatin (FOLFOX3) for metastatic colorectal cancer resistant to the same leucovorin and 5-fluorouracil regimen. Ann Oncol 9(11): 1251-1253, 1998.
13. André T, Tournigand C, Rosmorduc O et al: Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study. Ann Oncol 15: 1339-1343, 2004.
14. Therasse P, Arbuck SG, Eisenhauer EA et al: New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92: 205-216, 2000.
15. Kaplan EL and Meier P: Non-parametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958.
16. Trotti A, Colevas AD, Setser A et al: CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13(3): 176-181, 2003.
17. Varela M, Real MI, Burrel M et al: Chemoembolization of hepatocellular carcinoma with drug-eluting beads: efficacy and doxorubicin pharmacokinetics. JHepatol 46: 474-481, 2007.
18. Lewis AL, Taylor RR, Brenda H et al: Pharmacokinetic and safety study of doxorubicin-eluting beads in a porcine model of hepatic arterial embolization. J Vasc Interv Radiol 17: 1335-1343, 2006.
19. Lewis AL, Gonzalez MV, Lloyd AW et al: DC Bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization. J Vasc Interv Radiol 17: 335-342, 2006.
20. Aliberti C, Benea G, Tilli M et al: Chemoembolization (TACE) of unresectable intrahepatic cholangiocarcinoma with slow-release doxorubicin-eluting beads: preliminary results. Cardiovasc Intervent Radiol 31(5): 883-888, 2008.
21. Osuga K, Khankan A, Hori S et al: Transarterial embolization for large hepatocellular carcinoma with use of superabsorbent polymer microspheres: initial experience. J Vasc Interv Radiol 13: 929-934, 2002.
22. Bruix J, Sherman M, Llovet JM et al: Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35: 421-430, 2001.